Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 05, 2026 16:01 ET | Source: Cyclerion Therapeutics, Inc.

Cyclerion Therapeutics Announces Strategic Agreement with Medsteer and Progress Toward Initiating Phase 2 Proof-of-Concept Study for CYC-126 in Treatment-Resistant Depression

Cyclerion & Medsteer entered a strategic agreement to enable the integration of Medsteer's technology and know-how into CYC-126.